167 results on '"Marin, Concepció"'
Search Results
2. Olfactory Dysfunction in Mental Illness
3. Olfactory Function Assessment
4. Olfactory Bulb Excitotoxicity as a Gap-Filling Mechanism Underlying the Link Between Traumatic Brain Injury-Induced Secondary Neuronal Degeneration and Parkinson’s Disease-Like Pathology
5. Chronic Rhinosinusitis and COVID-19
6. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats
7. Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons
8. Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions
9. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease
10. The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries
11. Olfactory Dysfunction in Traumatic Brain Injury: the Role of Neurogenesis
12. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats
13. Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches
14. Olfactory Dysfunction in Neurodegenerative Diseases
15. Loss of smell in patients with traumatic brain injury is associated with neuropsychiatric behavioral alterations
16. ACE2 downregulation in olfactory mucosa: Eosinophilic rhinosinusitis as COVID‐19 protective factor?
17. Role of microRNAs in inflammatory upper airway diseases
18. Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways
19. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease
20. Reply
21. Catechol-O-Methyltransferase Inhibitors in Preclinical Models as Adjuncts of l-Dopa Treatment
22. In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model
23. The sense of smell in chronic rhinosinusitis
24. Loss of Smell in Allergic Rhinitis and Related Disorders
25. Functional organization of the basal ganglia: Therapeutic implications for Parkinsonʼs disease
26. Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology
27. Coadministration of Entacapone With Levodopa Attenuates the Severity of Dyskinesias in Hemiparkinsonian Rats
28. Role of microRNAs in inflammatory upper airway diseases.
29. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats
30. Intranigral infusion of interleukin-1β activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity
31. AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa
32. Systemic Administration of NMDA and AMPA Receptor Antagonists Reverses the Neurochemical Changes Induced by Nigrostriatal Denervation in Basal Ganglia
33. Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial
34. Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming
35. Self-perception of olfactory dysfunction is associated with history of Traumatic Brain Injury: post-hoc analysis from the OLFACAT survey.
36. Olfactory function in an excitotoxic model for secondary neuronal degeneration: Role of dopaminergic interneurons
37. A model of increased impulsivity in rats with bilateral parkinsonism treated with Pramipexole
38. In vivoevaluation of the dopaminergic neurotransmission system using [123I]FP-CIT SPECT in 6-OHDA lesioned rats
39. l‐dopa‐induced dyskinesias in unilateral 6‐hydroxydopamine‐lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata
40. Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)
41. In vivo evaluation of the dopaminergic neurotransmission system using [123I]FP-CIT SPECT in 6-OHDA lesioned rats.
42. Bilateral subthalamic nucleus lesion reverses L‐dopa‐induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats
43. AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated withl-dopa
44. Systemic Administration of NMDA and AMPA Receptor Antagonists Reverses the Neurochemical Changes Induced by Nigrostriatal Denervation in Basal Ganglia
45. MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats
46. Effect of long-term haloperidol treatment on striatal neuropeptides: Relation to stereotyped behavior
47. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity
48. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation
49. Ubiquitin in cerebral amyloid angiopathy
50. Effect of Gi protein ADP-ribosylation induced by pertussis toxin on dopamine-mediated behaviors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.